I thank the Minister for his extensive and helpful response, particularly on the comments made by my noble friend Lord Hunt about the groups that are consulted. This has been an excellent debate and I have little to add, as noble Lords put forward the issues so ably, in particular on the importance of listening to patients and patient representatives so that the consultation is meaningful and well thought through, given the enormous powers that are in the Bill and will be set out in the regulations. It is timely for my noble friend to remind us of the context of the DPRRC and Constitution Committee reports. I asked the Minister to consider whether Clause 41 should specifically include reference to consultation with the devolved authorities. If he could come back to me on that, that would be helpful. I also asked some questions about his correspondence, which I hope he will agree to follow up.
Medicines and Medical Devices Bill
Proceeding contribution from
Baroness Wheeler
(Labour)
in the House of Lords on Tuesday, 17 November 2020.
It occurred during Debate on bills
and
Committee proceeding on Medicines and Medical Devices Bill.
About this proceeding contribution
Reference
807 c647GC Session
2019-21Chamber / Committee
House of Lords Grand CommitteeSubjects
Librarians' tools
Timestamp
2024-08-22 11:12:36 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2020-11-17/20111775000029
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2020-11-17/20111775000029
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2020-11-17/20111775000029